In NAFLD, disrupted insulin signaling and heightened lipid accumulation are key contributors to hepatocyte injury, leading to increased levels of liver enzymes such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT), which serve as serum indicators of liver damage [12]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.